arrow
P

Petra Havránková

Charles University
H指数:20
被引数:1,736

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

KCNA2 ‐Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment

<scp> <i>KCNA2</i> </scp> 相关遗传性痉挛性截瘫痷:临床特征及靶向治疗依据

2026-10-070
PRE
Nanopore long-read sequencing facilitates accurate diagnosis of KMT2B-related dystonia

纳米孔长读测序促进KMT2B相关肌张力障碍的准确诊断

2026-09-170
OAAI
Monogenic forms of Parkinson's disease: a Czech cohort study

帕金森病的单基因形式:一项捷克队列研究

2026-05-010
PRE
Collaborative Genomics for Dystonia in Central and Eastern Europe: Successes Achieved, New Frontiers Ahead

中欧和东欧肌张力障碍的协作基因组学研究:已取得的成就,新的前沿在望

2026-04-020
OAAI
Fibroblast Transcriptomics in Molecular Diagnostics of a Comprehensive Dystonia Cohort

成纤维细胞转录组学在综合肌张力障碍队列分子诊断中的应用

2026-02-020
OAAI
Integrating Long-Read Nanopore Sequencing for Precision Resolution of Genomic Variants in Dystonia

整合长读长纳米孔测序技术以精确解析肌张力障碍中的基因组变异

2025-09-010
OAAI
Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia

整合基因组学和蛋白质组学揭示了肌张力障碍中难以捉摸的变异和广泛的病因异质性

BRAIN
IF11.7
2025-05-0110
OA
Variants of NAV3, a neuronal morphogenesis protein, cause intellectual disability, developmental delay, and microcephaly
2024-07-082
OAAI
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial
2022-02-22336
OA
WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia

WARS2突变引起多巴反应性早发性帕金森病和进行性肌阵挛性共济失调

2022-01-0119
OAAI